Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop

被引：27

作者：

Hirschberg, Rona ^{[1
]}

Ward, Lucy A. ^{[1
]}

Kilgore, Nicole ^{[2
]}

Kurnat, Rebecca ^{[2
]}

Schiltz, Helen ^{[1
]}

Albrecht, Mark T. ^{[3
]}

Christopher, George W. ^{[4
]}

Nuzum, Ed ^{[1
]}

机构：

[1] NIAID, Div Microbiol & Infect Dis, NIH, Bethesda, MD 20892 USA

[2] Med Countermeasure Syst, Dept Def, Frederick, MD 21702 USA

[3] Biodefense Adv Res & Dev Author, Assistant Secretary Preparedness & Response, Dept Hlth & Human Serv, Washington, DC 20201 USA

[4] Dept Def, Med Countermeasure Syst, Ft Belvoir, VA 22060 USA

来源：

VIRUSES-BASEL | 2014年 / 6卷 / 07期

关键词：

Ebola; Sudan; ebolavirus; Marburg virus; marburgvirus; Filoviridae; filovirus medical countermeasures; Filovirus Animal Non-clinical Group; FANG; HIV-1 ENV VACCINE; EBOLA-VIRUS; NONHUMAN-PRIMATES; ADENOVIRUS; PROTECTION; INFECTION; IMMUNOGENICITY; RESPONSES;

D O I：

10.3390/v6072673

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

On August 22-23, 2013, agencies within the United States Department of Defense (DoD) and the Department of Health and Human Services (HHS) sponsored the Filovirus Medical Countermeasures (MCMs) Workshop as an extension of the activities of the Filovirus Animal Non-clinical Group (FANG). The FANG is a federally-recognized multi-Agency group established in 2011 to coordinate and facilitate U. S. government (USG) efforts to develop filovirus MCMs. The workshop brought together government, academic and industry experts to consider the needs for filovirus MCMs and evaluate the status of the product development pipeline. This report summarizes speaker presentations and highlights progress and challenges remaining in the field.

引用

页码：2673 / 2697

页数：25

共 50 条

[1] An Interagency Collaboration to Facilitate Development of Filovirus Medical Countermeasures
Kilgore, Nicole
Nuzum, Edwin O.
[J]. VIRUSES-BASEL, 2012, 4 (10): : 2312 - 2316
[2] Workshop Proceedings: Challenges and Opportunities in Evaluating Protein Allergenicity Across Biotechnology Industries
Stagg, Nicola J.
Ghantous, Hanan N.
Ladics, Gregory S.
House, Robert V.
Gendel, Steven M.
Hastings, Kenneth L.
[J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2013, 32 (01) : 4 - 10
[3] Proceedings of the workshop on challenges for wordnets
[J]. 2017, CEUR-WS (1899):
[4] State of the Science of Cardioprotection: Challenges and Opportunities-Proceedings of the 2010 NHLBI Workshop on Cardioprotection
Kloner, Robert A.
Longacre, Lisa Schwartz
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 16 (3-4) : 223 - 232
[5] Progress and Challenges in Developing Medical Countermeasures for Chemical, Biological, Radiological, and Nuclear Threat Agents
Reddy, Doodipala Samba
[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2024, 388 (02): : 260 - 267
[6] The Challenges, Opportunities and Countermeasures of Golf Clubs in China
Rong, Jing
Han, Lifei
Song, Wei
[J]. PROCEEDINGS OF THE 2013 INTERNATIONAL WORKSHOP ON COMPUTER SCIENCE IN SPORTS, 2013, : 70 - 73
[7] REPORT ON THE PROCEEDINGS OF THE WORKSHOP ON MEDICAL RESPONSIBILITY
MACALEESE, H
[J]. JOURNAL DE MEDECINE LEGALE DROIT MEDICAL, 1981, 24 (01): : 49 - 52
[8] The Progress,Challenges and Countermeasures of the Labor Contract Law
Xie Zengyi Associate researcher at the Institute of Law
[J]. China's Foreign Trade, 2009, (07) : 35 - 37
[9] Phototherapy:progress,challenges,and opportunities
Xi Yuan
JunLiang Zhou
Lin Yuan
Jiangli Fan
Juyoung Yoon
XiaoBing Zhang
Xiaojun Peng
Weihong Tan
[J]. Science China(Chemistry), 2025, 68 (03) - 865
[10] Flexomagnetism: Progress, challenges, and opportunities
Tang, Ziming
Gong, Qihua
Yi, Min
[J]. Materials Science and Engineering R: Reports, 2025, 162

← 1 2 3 4 5 →